Skip to content

Neurophysiology of Locomotor Adaptation and Freezing of Gait in Parkinson's Disease

Neurophysiology of Locomotor Adaptation and Freezing of Gait in Parkinson's Disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06911229
Enrollment
60
Registered
2025-04-04
Start date
2025-10-01
Completion date
2027-07-31
Last updated
2026-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Freezing of gait, deep brain stimulation

Brief summary

Locomotor adaptation will be studied using an established split-belt treadmill paradigm, consisting of baseline (1:1 speed ratio), split-belt adaptation (2:1) and post-adaptation (1:1) walking. Split-belt walking will be performed under DBS ON and DBS OFF conditions, while off-medication.

Detailed description

We will test the hypotheses that DBS can facilitate split-belt walking adaptation with DBS ON compared with DBS OFF.

Interventions

Patients will receive DBS in the clinically-optimized setting.

Sponsors

University of Florida
Lead SponsorOTHER
National Institute on Aging (NIA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* consensus diagnosis of idiopathic PD by fellowship trained movement disorders neurologists at the Normal Fixel Institute of Neurological Diseases; * chronically stable DBS, defined as having had DBS for at least 6 months in duration with optimized DBS settings; * Age between 18 - 80 years old per the FDA data sheet for PD DBS; * no dementia according to the clinical diagnostic criteria for PD dementia; * ambulatory without the use of walking aids, or another person's assistance.

Exclusion criteria

* other previous neurological surgery; * suspicion of other neurologic diagnoses such as atypical parkinsonism, or Alzheimer's disease.

Design outcomes

Primary

MeasureTime frameDescription
Step length rate of adaptation1 hourThe rate of adaptation in step length asymmetry is estimated by fitting an exponential decay function to step length asymmetry over the first 100 strides in adaptation.
Step length magnitude of adaptation1 hourThe magnitude of adaptation in step length asymmetry is calculated as the mean difference in step length asymmetry between early and late adaptation.
Step length after-effects1 hourThe after-effect in step length asymmetry is calculated as the mean difference in step length asymmetry between baseline and early post-adaptation.

Countries

United States

Contacts

CONTACTJulia Choi, Ph.D.
juliachoi@ufl.edu3522941720

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 16, 2026